In the case of SARS-CoV-2 and in support of the beneficial use of CP, a recent meta-analysis showed that CP administration was associated with a significant reduction in mortality [16], whereas the transfusion of CP in 20,000 COVID-19 patients proved that it is safe and carries a very low risk of complications [17]. The gene discussed is CP; the disease is COVID-19.